How We Operate

The Reagan-Udall Foundation for the FDA (“the Foundation”) is an independent 501(c)(3) not-for profit organization created by Congress to further the mission of the FDA  by advancing regulatory science and research with the goal of improving public health. The Foundation provides a unique opportunity to bring together all stakeholders (FDA, Patient Groups, Consumers, Academia, Industry, and others) to create public private partnerships to meet the needs of the FDA as well as the needs of the stakeholder constituencies.

Given these stakeholder groups’ shared interests, it is natural that they should work together, and the Foundation is playing a key role in facilitating and promoting cooperation between them. However, the Foundation also recognizes that its participation in these public-private partnerships raises the potential for actual or potential conflicts of interest with the goals of individual stakeholders.  For this reason, the Reagan-Udall Foundation for the FDA is committed to conducting its operations in a transparent, trustworthy and scientifically-supported manner.

We share below our governance structure, financial information, our transparency policies and procedures, and other information relating to the Foundation’s efforts to address actual or potential conflicts of interest. We continue to try to develop more and better ways to solicit and get input from all stakeholder groups, and to routinely share more information about what we are doing and how we are making decisions. We welcome suggestions on ways to better accomplish this.

The Reagan-Udall Foundation for the FDA is an independent 501(c)(3) not-for-profit organization, created by Congress in the Food and Drug Administration Amendments Act of 2007 (FDAAA 2007). Find out more about how the Foundation funds its core operations and projects, including a list of funding sources to date.
The Reagan-Udall Foundation for the FDA receives funding from a variety of sources. Find out more about how the Foundation funds its core operations and projects, including a list of funding sources to date.
Appendix A, Part V of the Reagan-Udall Foundation for the FDA by-laws, require the Foundation to list all 990 IRS filings and annual reports. Find out more information about the Foundation’s 990 IRS filings and financial audit reports.
Project ideas and programs evolve and develop from within the Foundation and as a result of input received from outside partners. All projects are subject to a rigorous review process to ensure they both align with and support the mission of the RUF as well as the mission of the FDA. Learn more about the Foundation’s review process.
The Reagan-Udall Foundation by-laws outline the conflict of interest policies that have been put into place to ensure that no one entity or organization has undue influence on Foundation initiatives and projects. Review the Foundation’s conflict of interest policies and financial disclosure forms.